A Potential Role for Auto-Graft Immune Cell Subsets to Influence Post-Transplant Outcomes in Multiple Myeloma

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2014.11.178
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Bortezomib Administered Pre-Auto-SCT and as Maintenance Therapy Post Transplant for Multiple Myeloma: A Single Institution Phase II Study

Bone Marrow Transplantation
TransplantationHematology
2008English

Early Recovery of Aggressive Cytotoxic Cells and Improved Immune Resurgence With Post-Transplant Immunotherapy for Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2007English

CD3+ Graft Cell Count Influence on Chronic GVHD in Haploidentical Allogeneic Transplantation Using Post-Transplant Cyclophosphamide

Bone Marrow Transplantation
TransplantationHematology
2018English

Multiple Myeloma With Concomitant JAK2-positive Essential Thrombocythemia Post-Successful Autologous Peripheral Blood Hematopoietic Stem Cell Transplant

Bone Marrow Transplantation
TransplantationHematology
2010English

Dynamics of Immune Cell Reconstitution in Allogeneic Hematopoietic Cell Transplant Patients Receiving Post-Transplant Cyclophosphamide (PTCy)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Role of Lymphocyte Subsets in the Immune Response to Primary B Cell–Derived Exosomes

Journal of Immunology
AllergyImmunology
2017English

A Flowcytometric Analysis to Efficiently Quantify Multiple Innate Immune Cells and T Cell Subsets in Human Blood

Cytometry Part A
Forensic MedicinePathologyHistologyCell Biology
2017English

The Therapeutic Potential of Cell Cycle Targeting in Multiple Myeloma

Oncotarget
Oncology
2017English

Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma

Seminars in Hematology
Hematology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy